Dowling & Yahnke LLC Has $2.02 Million Holdings in Aflac Incorporated (NYSE:AFL)

Dowling & Yahnke LLC cut its stake in shares of Aflac Incorporated (NYSE:AFLGet Rating) by 2.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,342 shares of the financial services provider’s stock after selling 857 shares during the period. Dowling & Yahnke LLC’s holdings in Aflac were worth $2,018,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. National Bank of Canada FI bought a new stake in shares of Aflac in the fourth quarter worth $1,820,000. Van ECK Associates Corp grew its stake in shares of Aflac by 6.3% in the fourth quarter. Van ECK Associates Corp now owns 66,580 shares of the financial services provider’s stock worth $3,888,000 after purchasing an additional 3,935 shares during the last quarter. Community Bank N.A. grew its stake in shares of Aflac by 266.4% in the fourth quarter. Community Bank N.A. now owns 4,848 shares of the financial services provider’s stock worth $283,000 after purchasing an additional 3,525 shares during the last quarter. State of Michigan Retirement System grew its stake in shares of Aflac by 8.7% in the fourth quarter. State of Michigan Retirement System now owns 187,777 shares of the financial services provider’s stock worth $10,964,000 after purchasing an additional 15,072 shares during the last quarter. Finally, Dearborn Partners LLC grew its stake in shares of Aflac by 6.3% in the fourth quarter. Dearborn Partners LLC now owns 13,487 shares of the financial services provider’s stock worth $788,000 after purchasing an additional 803 shares during the last quarter. 66.45% of the stock is currently owned by institutional investors and hedge funds.

Aflac Trading Up 0.6 %

AFL opened at $56.00 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.06 and a quick ratio of 0.06. Aflac Incorporated has a fifty-two week low of $51.28 and a fifty-two week high of $67.20. The firm has a market capitalization of $36.07 billion, a PE ratio of 9.20, a P/E/G ratio of 2.14 and a beta of 0.96. The company’s 50-day moving average is $56.10 and its 200 day moving average is $60.14.

Aflac (NYSE:AFLGet Rating) last posted its earnings results on Wednesday, April 27th. The financial services provider reported $1.42 earnings per share for the quarter, topping analysts’ consensus estimates of $1.38 by $0.04. Aflac had a net margin of 18.90% and a return on equity of 11.96%. The company had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. During the same quarter in the prior year, the business posted $1.53 EPS. As a group, research analysts predict that Aflac Incorporated will post 5.21 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Morgan Stanley reduced their price objective on shares of Aflac from $69.00 to $66.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 6th. Evercore ISI cut their price target on shares of Aflac from $60.00 to $59.00 and set an “in-line” rating on the stock in a research report on Wednesday, July 6th. Citigroup initiated coverage on shares of Aflac in a research report on Monday, May 23rd. They set a “neutral” rating and a $60.00 price target on the stock. StockNews.com initiated coverage on shares of Aflac in a research report on Thursday, March 31st. They set a “hold” rating on the stock. Finally, JPMorgan Chase & Co. upped their price target on shares of Aflac from $61.00 to $62.00 in a research report on Monday, July 11th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $62.08.

About Aflac

(Get Rating)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

See Also

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.